{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:27Z","timestamp":1786997907186,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FN110046"],"award-info":[{"award-number":["FN110046"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004261","name":"Research Development Corporation of Newfoundland and Labrador","doi-asserted-by":"crossref","award":["5404.1133.102"],"award-info":[{"award-number":["5404.1133.102"]}],"id":[{"id":"10.13039\/501100004261","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.vph.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T16:32:16Z","timestamp":1503073936000},"page":"40-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cerebrovascular recovery after stroke with individual and combined losartan and captopril treatment of SHRsp"],"prefix":"10.1016","volume":"96-98","author":[{"given":"John S.","family":"Smeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Daneshtalab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2017.08.004_bb0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.STR.24.7.987","article-title":"Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality","volume":"24","author":"Broderick","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2017.08.004_bb0010","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.wnl.0000208408.98482.99","article-title":"Hematoma growth is a direct predictor of mortality and poor outcome after intracerebral hemorrhage","volume":"66","author":"Davis","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.vph.2017.08.004_bb0015","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/01.STR.20.9.1212","article-title":"Hemorrhagic stroke development in spontaneously hypertensive rats fed a North American Japanese-style diet","volume":"20","author":"Smeda","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2017.08.004_bb0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/jcbfm.2010.110","article-title":"The effects of post stroke captopril and losartan treatment on cerebral blood flow autoregulation after hemorrhagic stroke","volume":"31","author":"Smeda","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.vph.2017.08.004_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1753944716644131","article-title":"Mega trials which have shaped the RAS intervention clinical practice","volume":"10","author":"D\u00fcsing","year":"2016","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.vph.2017.08.004_bb0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-159-11-201312030-00009","article-title":"Screening monitoring and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians","volume":"159","author":"Qaseem","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vph.2017.08.004_bb0035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1139\/y92-070","article-title":"Cerebral vascular changes associated with hemorrhagic stroke in hypertension","volume":"70","author":"Smeda","year":"1992","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.vph.2017.08.004_bb0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1139\/y97-093","article-title":"Renal function in stroke-prone rats fed a high-K+ diet","volume":"75","author":"Smeda","year":"1997","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.vph.2017.08.004_bb0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-3565(24)35140-7","article-title":"Effect of poststroke captopril treatment on mortality associated with hemorrhagic stroke in stroke-prone rats","volume":"291","author":"Smeda","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2017.08.004_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1148\/radiographics.18.2.9536483","article-title":"Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction","volume":"18","author":"Port","year":"1998","journal-title":"Radiographics"},{"key":"10.1016\/j.vph.2017.08.004_bb0055","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1212\/WNL.0000000000002527","article-title":"Chronic kidney disease, cerebral blood flow, and white matter volume hypertensive adults","volume":"86","author":"Tamura","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.vph.2017.08.004_bb0060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1474-4422(14)70026-2","article-title":"Stroke and cerebrovascular disease in patients with chronic kidney disease","volume":"13","author":"Toyoda","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.vph.2017.08.004_bb0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.STR.29.3.635","article-title":"Serum uric acid is a strong predictor of stroke in patients with non-insulin dependent diabetes","volume":"29","author":"Lehto","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2017.08.004_bb0070","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","article-title":"The impact of serum uric acid on cardiovascular outcomes in the LIFE study","volume":"65","author":"H\u00f8ieggen","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.vph.2017.08.004_bb0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.jhh.1001916","article-title":"Possible pathophysiological mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotensin converting enzyme inhibitors","volume":"19","author":"Chrysant","year":"2005","journal-title":"J. Human Hypertens."},{"key":"10.1016\/j.vph.2017.08.004_bb0080","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1358\/dot.2004.40.9.850498","article-title":"Stroke prevention with losartan in the context of other antihypertensive drugs","volume":"40","author":"Chyrsant","year":"2004","journal-title":"Drugs Today (Barc.)"},{"key":"10.1016\/j.vph.2017.08.004_bb0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cvr\/cvp395","article-title":"Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke","volume":"86","author":"Daneshtalab","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2017.08.004_bb0090","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.STR.25.7.1456","article-title":"Effects of local reductions in pressure on endothelium-dependent responses of cerebral arteriole","volume":"25","author":"Baumbach","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2017.08.004_bb0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.STR.30.3.656","article-title":"Cerebrovascular alterations in protein kinase C-mediated constriction in stroke-prone rats","volume":"30","author":"Smeda","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2017.08.004_bb0100","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/01.STR.0000073797.91891.9E","article-title":"Stroke development in stroke-prone spontaneously hypertensive rats alters the ability of cerebrovascular muscle to utilize internal Ca2+ to elicit constriction","volume":"34","author":"Smeda","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2017.08.004_bb0105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.STR.31.3.751","article-title":"Electromechanical alterations in the cerebrovasculature of stroke-prone rats","volume":"31","author":"Smeda","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2017.08.004_bb0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.peptides.2009.11.026","article-title":"Protease-activated receptor 2 and bradykinin mediated vasodilation in the cerebral arteries of stroke prone rats","volume":"31","author":"Smeda","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.vph.2017.08.004_bb0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/hh0302.105662","article-title":"Transient receptor potential channels regulate myogenic tone of resistance arteries","volume":"90","author":"Welsh","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2017.08.004_bb0120","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1440-1681.2007.04855.x","article-title":"Transient receptor potential (TRP) channels, vascular tone and autoregulations of cerebral blood flow","volume":"35","author":"Brayden","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.vph.2017.08.004_bb0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0006-291X(89)91071-1","article-title":"Protein Kinase C potentiates stretch-induced cerebral artery tone by increasing intracellular sensitivity to Ca+2","volume":"165","author":"Laher","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2017.08.004_bb0130","first-page":"H1178","article-title":"Increased Ca2+ sensitivity as a key mechanism of PKC-induced constriction in pressurized cerebral arteries","volume":"277","author":"Gokina","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.vph.2017.08.004_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(92)90067-5","article-title":"Signal transduction of V1-vascular vasopressin receptors","volume":"38","author":"Thibonnier","year":"1992","journal-title":"Regul. Pept."},{"key":"10.1016\/j.vph.2017.08.004_bb0140","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1172\/JCI200318684","article-title":"Modulation of the molecular composition of large conductance, Ca2+-activated K+ channels in vascular smooth muscle during hypertension","volume":"112","author":"Amberg","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2017.08.004_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.HYP.0000022606.52221.2F","article-title":"Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats","volume":"40","author":"Naruse","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2017.08.004_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/147323000102900103","article-title":"Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy","volume":"29","author":"Sato","year":"2001","journal-title":"J. Int. Med. Res."},{"issue":"4","key":"10.1016\/j.vph.2017.08.004_bb0155","first-page":"H1212","article-title":"Cerebral artery responses to pressure and flow in uremic hypertensive and spontaneously hypertensive rats","volume":"284","author":"New","year":"2003","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2017.08.004_bb0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1185\/030079904125002982","article-title":"Uric acid: role in cardiovascular disease and effects of losartan","volume":"20","author":"Alderman","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.vph.2017.08.004_bb0165","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/10641969709084508","article-title":"Acceleration of hypertensive cerebral injury by the inhibition of xanthine-xanthine oxidase system in stroke-prone spontaneously hypertensive rats","volume":"19","author":"Maenishi","year":"1997","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.vph.2017.08.004_bb0170","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.hjh.0000166845.49850.39","article-title":"Negative regulation of RhoA\/rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats","volume":"23","author":"Savoia","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2017.08.004_bb0175","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3892\/mmr.2015.4641","article-title":"Prehypertensive treatment with losartan, however not amlodipine, leads to long-term effects on blood pressure and reduces the risk of stroke in spontaneously hypertensive stroke-prone rats","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.vph.2017.08.004_bb0180","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1291\/hypres.29.865","article-title":"Olmesartan is an angiotensin II reception blocker with an inhibitory effect on angiotensin-converting enzyme","volume":"29","author":"Agata","year":"2006","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.vph.2017.08.004_bb0185","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00004872-199310000-00008","article-title":"Vascular conversion of angiotensin I in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats","volume":"11","author":"Hilgers","year":"1993","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2017.08.004_bb0190","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1097\/HJH.0b013e3283311ba1","article-title":"Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage","volume":"27","author":"Gelosa","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2017.08.004_bb0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2008.01.003","article-title":"Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure","volume":"19","author":"Carey","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.vph.2017.08.004_bb0200","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","article-title":"Effects of renin-angiotensin system blockage on renal angiotensin-(1-7) forming enzymes and receptors","volume":"68","author":"Ferrario","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.vph.2017.08.004_bb0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1753944715597623","article-title":"ACE2 and vasoactive peptides: novel players in cardiovascular\/renal remodeling and hypertension","volume":"9","author":"Mendozza-Torres","year":"2015","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.vph.2017.08.004_bb0210","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1590\/S0100-879X2011007500093","article-title":"Alternative pathways for angiotensin II generation","volume":"44","author":"Becari","year":"2011","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.vph.2017.08.004_bb0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1291\/hypres.24.189","article-title":"Local angiotensin II-generating system in vascular tissues: the roles of chymase","volume":"24","author":"Miyazaki","year":"2001","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.vph.2017.08.004_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cvr\/cvp003","article-title":"Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics","volume":"82","author":"Prosser","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2017.08.004_bb0225","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI9997","article-title":"A novel vascular smooth muscle chymase is upregulated in hypertensive rats","volume":"107","author":"Guo","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2017.08.004_bb0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.HYP.20.3.280","article-title":"K, Yamamoto. Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats","volume":"20","author":"Kim","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2017.08.004_bb0235","first-page":"H565","article-title":"Angiotensin-converting enzyme inhibition augments the expression of rat elastase-2, an angiotensin II-forming enzyme","volume":"301","author":"Becari","year":"2011","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.vph.2017.08.004_bb0240","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary stroke prevention. Principal results of a randomized controlled study (MOSES)","volume":"36","author":"Shrader","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2017.08.004_bb0245","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/HJH.0b013e328306ebe2","article-title":"Comparisons between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a mta-analysis","volume":"26","author":"Reboldi","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2017.08.004_bb0250","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hempill","year":"2015","journal-title":"Stroke"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189117301143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189117301143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:32:51Z","timestamp":1750793571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189117301143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":50,"alternative-id":["S1537189117301143"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2017.08.004","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrovascular recovery after stroke with individual and combined losartan and captopril treatment of SHRsp","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}